A case with a novel GATA1 variant mimicking immune thrombocytopenia attacks
One of the leading thrombocytopenia occasions in childhood is immune thrombocytopenia (ITP). Small number of these patients do not respond to treatment methods known to be effective for ITP such as corticosteroids, intravenous immunoglobulin and thrombopoietin receptor agonists (eltrombopag, romiplo...
Saved in:
| Main Authors: | Elif Habibe Aktekin, Serdar Ceylaner, Şeyda Beşen, Ayşe Erbay, Nalan Yazıcı |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Platelets |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/09537104.2025.2500499 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
by: Davide Scalabrini, et al.
Published: (2023-08-01) -
Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia
by: O. Yu. Vinogradova, et al.
Published: (2024-12-01) -
Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia
by: S. G. Zakharov, et al.
Published: (2024-04-01) -
Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia
by: Paschalis Evangelidis, et al.
Published: (2025-01-01) -
Literature Review and Experts’ Opinion for Managing Thrombocytopenia in Chronic Liver Disease
by: Faisal Alsayegh, et al.
Published: (2025-01-01)